Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 247 (8%) | |
| Anticipated shortage: | 14 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-03-05 | 2019-09-05 | 77869 |
| APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-03-06 | 2019-09-09 | 77974 |
| APO-ALPRAZ | 0.25MG | TABLET | Resolved | 2019-03-20 | 2019-09-16 | 79036 |
| APO-ALPRAZ | 1MG | TABLET | Resolved | 2019-04-24 | 2019-08-02 | 82331 |
| APO-ALPRAZ | .5MG | TABLET | Resolved | 2019-09-09 | 2019-09-16 | 93262 |
| APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2021-11-26 | 2021-12-06 | 150059 |
| APO-ALPRAZ | 0.5MG | TABLET | Resolved | 2024-03-27 | 2024-05-03 | 223546 |
| APO-ALPRAZ TS | 2MG | TABLET | Resolved | 2017-06-07 | 2017-10-24 | 12241 |
| APO-ALPRAZ TS | 2MG | TABLET | Resolved | 2018-07-04 | 2020-09-28 | 54168 |
| APO-AMBRISENTAN | 5MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139394 |
| APO-AMBRISENTAN | 10MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139397 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2018-05-15 | 2018-11-02 | 49418 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2020-10-07 | 2020-12-07 | 125800 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2023-03-23 | 2023-05-06 | 187727 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2023-09-15 | 2023-09-28 | 204408 |
| APO-AMIODARONE TABLETS | 200MG | TABLET | Resolved | 2024-05-24 | 2024-06-07 | 228816 |
| APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-06-04 | 2021-06-28 | 140414 |
| APO-AMITRIPTYLINE | 10MG | TABLET | Resolved | 2021-06-25 | 2021-08-31 | 141518 |
| APO-AMITRIPTYLINE | 25MG | TABLET | Resolved | 2021-08-16 | 2022-05-13 | 144195 |
| APO-AMITRIPTYLINE | 50MG | TABLET | Resolved | 2021-10-08 | 2022-05-13 | 146901 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | 250MG 62.5MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4906 |
| APO-AMOXI CLAV 250MG/62.5MG PER 5ML | Discontinued | 2019-05-13 | 2019-05-13 | 83981 | ||
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60249 |
| APO-AMOXI SUGAR FREE | 250MG | POWDER FOR SUSPENSION | Discontinued | 2020-06-22 | 2020-06-22 | 118526 |
| APO-ASA LD | 81MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60252 |
| APO-ATENOL TAB 100MG | 100MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60261 |
| APO-ATENOL TAB 50MG | 50MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60267 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60273 |
| APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
| APO-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-09-07 | 2019-02-13 | 60279 |
| APO-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-09-07 | 2018-11-09 | 60282 |
| APO-ATORVASTATIN | 80MG | TABLET | Discontinued | 2018-09-07 | 2018-12-29 | 60285 |
| APO-BICALUTAMIDE | 50MG | TABLET | Discontinued | 2022-03-25 | 2022-05-13 | 157376 |
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |